Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice.
A reduction in glucocorticoid receptor (GR) function leads to hippocampus-dependent allocentric spatial learning deficits, altered novelty exploration and disrupted hippocampal long-term potentiation (LTP) in transgenic mice expressing a GR antisense construct. After continuous long-term treatment of these mice with moclobemide (a reversible inhibitor of monoamine oxidase A), spatial navigation performance but not accuracy improved during initial acquisition. These changes were associated with a shift of the threshold for the induction of hippocampal LTP at low stimulation frequencies. Moreover, novel object exploration increased in both control and transgenic animals following long-term treatment with moclobemide. These findings open the possibility that antidepressants might improve hippocampal function under conditions of impaired stress hormone regulation, and that these drugs might in part act through this mechanism to attenuate cognitive deficiency in disorders such as depression.
Steckler
T
T
Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804, Munich, Germany. steckler@mpipsykl.mpg.de
Rammes
G
G
Sauvage
M
M
van Gaalen
M M
MM
Weis
C
C
Zieglgänsberger
W
W
Holsboer
F
F
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects*; D018782:Maze Learning / Q000187:drug effects; D051379:Mice; D008822:Mice, Transgenic; D020912:Moclobemide / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009473:Neuronal Plasticity / Q000187:drug effects*; D011965:Receptors, Glucocorticoid / Q000187:drug effects*; D012153:Retention, Psychology / Q000502:physiology; D013037:Spatial Behavior / Q000187:drug effects; D013997:Time Factors
D008996:Monoamine Oxidase Inhibitors; D011965:Receptors, Glucocorticoid; D020912:Moclobemide